Ravulizumab for the Treatment of aHUS in Adults: Improving Quality of Life
Kidney Int Rep
.
2021 May 12;6(6):1489-1491.
doi: 10.1016/j.ekir.2021.04.036.
eCollection 2021 Jun.
Authors
Christophe Legendre
1
,
Rebecca-Sberro-Soussan
1
,
Julien Zuber
1
2
Affiliations
1
Service de Néphrologie-Transplantation, Hôpital Necker, Paris and Université de Paris, Paris, France.
2
Human Lymphohematopoiesis Laboratory, Inserm UMR_S1163, Imagine Institute, Paris, France.
PMID:
34169186
PMCID:
PMC8207465
DOI:
10.1016/j.ekir.2021.04.036
No abstract available
Publication types
Editorial